What this study is
The purpose of this study is to examine how different messages about risk of skin cancer can impact the uptake of skin cancer prevention activities.
What's being tested
- Precision Prevention Booklet
Intervention · BEHAVIORAL
Precision prevention booklet anchored in their MC1R risk that incorporates gold-standard risk communication strategies, including visual risk representations and simple language.
- Standard Prevention Booklet
Intervention · BEHAVIORAL
Standard materials are similar in content to the precision prevention booklet but without any reference to MC1R risk.
Study details
- Official title
- A Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in Federal Qualified Health Centers
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Conditions
- Skin Cancer
- Enrolling
- 2,900 people
- Starts
- 2025-10-10
- Est. completion
- 2030-10-10
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers AcceptedYou may qualify if
- Be a patient of any race or ethnicity attending one of the six Tampa Family Health Centers.
- Be 18 years of age or older.
- Self-report skin cancer risk behaviors within the past 12 months, including: Intentional sun exposure (e.g., outdoor or indoor tanning) or unintentional sun exposure leading to sunburn.
- Be willing to complete a baseline questionnaire and provide a saliva sample for MC1R genotyping.
- Be able to provide informed consent (written or electronic).
- Prefer English or Spanish for communication and study materials.
You can't join if
- Do not report any skin cancer risk behaviors (i.e., no tanning or sunburning in the past 12 months).
- Are unwilling or unable to complete the baseline assessment or return the saliva kit.
- Decline to provide informed consent.
- Are under 18 years of age.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
1 openMoffitt Cancer Center
Tampa, Florida, United States
- Peter Kanetsky, PhD, MPH · Principal investigator
- Margaret Byrne, PhD · Sub-investigator
- Susan Vadaparampil, PhD · Sub-investigator
RecruitingMemorial Sloan Kettering Cancer Center
New York, New York, United States
Active, not recruiting
Study team
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Study ID MCC-23436
Principal investigator
Peter Kanetsky, PhD, MPH
Moffitt Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.